The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.
Centers for Disease Control and Prevention. Cancer survivors— United States, 2007. MMWR Morb Mortal Wkly Rep 2011;60:269–272.
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. Published online June 23, 2022. doi: 10.3322/caac.21731
Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363–385.
Ha DM, Prochazka AV, Bekelman DB, et al. Association of leisure-time physical activity with health-related quality of life among US lung cancer survivors. JNCI Cancer Spectr 2021;5:pkaa118.
Schwedhelm C, Boeing H, Hoffmann G, et al. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev 2016;74:737–748.
Petrelli F, Cortellini A, Indini A, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open 2021;4:e213520.
Friedenreich CM, Stone CR, Cheung WY, et al. Physical activity and mortality in cancer survivors: a systematic review and meta-analysis. JNCI Cancer Spectr 2019;4:pkz080.
Campbell PT, Patel AV, Newton CC, et al. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 2013;31:876–885.
Kabat GC, Matthews CE, Kamensky V, et al. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr 2015;101:558–569.
Inoue-Choi M, Lazovich D, Prizment AE, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health- related quality of life among elderly female cancer survivors. J Clin Oncol 2013;31:1758–1766.
Lee IM, Wolin KY, Freeman SE, et al. Physical activity and survival after cancer diagnosis in men. J Phys Act Health 2014;11:85–90.
Van Blarigan EL, Fuchs CS, Niedzwiecki D, et al. Association of survival with adherence to the American Cancer Society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: the CALGB 89803/Alliance trial. JAMA Oncol 2018;4:783–790.
Wyszynski A, Tanyos SA, Rees JR, et al. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer 2014;120:408–414.
Karavasiloglou N, Pestoni G, Wanner M, et al. Healthy lifestyle is inversely associated with mortality in cancer survivors: results from the Third National Health and Nutrition Examination Survey (NHANES III). PLoS One 2019;14:e0218048.
Kehm RD, MacInnis RJ, John EM, et al. Recreational physical activity and outcomes after breast cancer in women at high familial risk. JNCI Cancer Spectr 2021;5:pkab090.
De Cicco P, Catani MV, Gasperi V, et al. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence. Nutrients 2019;11:1514.
Ligibel JA, Pierce LJ, Bender CM, et al. Attention to diet, exercise, and weight in oncology care: results of an American Society of Clinical Oncology national patient survey. Cancer 2022;128:2817–2825.
Hyland KA, Jacobs JM, Lennes IT, et al. Are cancer survivors following the National Comprehensive Cancer Network health behavior guidelines? An assessment of patients attending a cancer survivorship clinic. J Psychosoc Oncol 2018;36:64–81.
Arem H, Mama SK, Duan X, et al. Prevalence of healthy behaviors among cancer survivors in the United States: how far have we come? Cancer Epidemiol Biomarkers Prev 2020;29:1179–1187.
Asare M, McIntosh S, Culakova E, et al. Assessing physical activity behavior of cancer survivors by race and social determinants of health. Int Q Community Health Educ 2019;40:7–16.
Byrd DA, Agurs-Collins T, Berrigan D, et al. Racial and ethnic differences in dietary intake, physical activity, and body mass index (BMI) among cancer survivors: 2005 and 2010 National Health Interview Surveys (NHIS). J Racial Ethn Health Disparities 2017;4:1138–1146.
Cancino RS, Su Z, Mesa R, et al. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer 2020;6:e21697.
Vanderbruggen N, Matthys F, Van Laere S, et al. Self-reported alcohol, tobacco, and cannabis use during COVID-19 lockdown measures: results from a web-based survey. Eur Addict Res 2020;26:309–315.
Knell G, Robertson MC, Dooley EE, et al. Health behavior changes during COVID-19 pandemic and subsequent “stay-at-home” orders. Int J Environ Res Public Health 2020;17:6268.
Irwin ML, Cartmel B, Harrigan M, et al. Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer 2017;123:1249–1258.
Brown JC, Giobbie-Hurder A, Yung RL, et al. The effects of a clinic-based weight loss program on health-related quality of life and weight maintenance in cancer survivors: a randomized controlled trial. Psychooncology 2022;31:326–333.
Shaikh H, Bradhurst P, Ma LX, et al. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev 2020;12:CD012110.
Smits A, Lopes A, Das N, et al. The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol 2015;139:546–552.
Menichetti J, Villa S, Magnani T, et al. Lifestyle interventions to improve the quality of life of men with prostate cancer: a systematic review of randomized controlled trials. Crit Rev Oncol Hematol 2016;108:13–22.
Moug SJ, Bryce A, Mutrie N, et al. Lifestyle interventions are feasible in patients with colorectal cancer with potential short-term health benefits: a systematic review. Int J Colorectal Dis 2017;32:765–775.
Thomson ZO, Reeves MM. Can weight gain be prevented in women receiving treatment for breast cancer? A systematic review of intervention studies. Obes Rev 2017;18:1364–1373.
Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814–5830.
Demark-Wahnefried W, Jones LW. Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am 2008;22:319–342;viii.
Satia JA, Campbell MK, Galanko JA, et al. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev 2004;13:1022–1031.
Tan SY, Wong HY, Vardy JL. Do cancer survivors change their diet after cancer diagnosis? Support Care Cancer 2021;29:6921–6927.
Jones LW, Courneya KS, Fairey AS, et al. Effects of an oncologist’s recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 2004;28:105–113.
Sabatino SA, Coates RJ, Uhler RJ, et al. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol 2007;25:2100–2106.
Stump TK, Robinson JK, Yanez B, et al. Physicians’ perspectives on medication adherence and health promotion among cancer survivors. Cancer 2019;125:4319–4328.
Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81–95.
Bandura A. Health promotion by social cognitive means. Health Educ Behav 2004;31:143–164.
Short CE, James EL, Plotnikoff RC. How social cognitive theory can help oncology-based health professionals promote physical activity among breast cancer survivors. Eur J Oncol Nurs 2013;17:482–489.
Bennett JA, Lyons KS, Winters-Stone K, et al. Motivational interviewing to increase physical activity in long-term cancer survivors: a randomized controlled trial. Nurs Res 2007;56:18–27.
Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Educ Couns 2004;53:147–155.
Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003;71:843–861.
Hwang NK, Jung YJ, Park JS. Information and communications technology-based telehealth approach for occupational therapy interventions for cancer survivors: a systematic review. Healthcare (Basel) 2020;8:355.
Mbous YP, Patel J, Kelly KM. A systematic review and meta-analysis of physical activity interventions among colorectal cancer survivors. Transl Behav Med 2020;10:1134–1143.
Demark-Wahnefried W, Morey MC, Sloane R, et al. Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors. J Clin Oncol 2012;30:2354–2361.
Goode AD, Lawler SP, Brakenridge CL, et al. Telephone, print, and web-based interventions for physical activity, diet, and weight control among cancer survivors: a systematic review. J Cancer Surviv 2015;9:660–682.
Goodwin PJ, Segal RJ, Vallis M, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 2014;32:2231–2239.
Hawkes AL, Chambers SK, Pakenham KI, et al. Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol 2013;31:2313–2321.
Lynch BM, Courneya KS, Sethi P, et al. A randomized controlled trial of a multiple health behavior change intervention delivered to colorectal cancer survivors: effects on sedentary behavior. Cancer 2014;120:2665–2672.
Pinto BM, Frierson GM, Rabin C, et al. Home-based physical activity intervention for breast cancer patients. J Clin Oncol 2005;23:3577–3587.
Stacey FG, James EL, Chapman K, et al. A systematic review and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior change interventions for cancer survivors. J Cancer Surviv 2015;9:305–338.
Short CE, James EL, Girgis A, et al. Main outcomes of the Move More for Life trial: a randomised controlled trial examining the effects of tailored-print and targeted-print materials for promoting physical activity among post-treatment breast cancer survivors. Psychooncology 2015;24:771–778.
Vallance JKH, Courneya KS, Plotnikoff RC, et al. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol 2007;25:2352–2359.
James EL, Stacey FG, Chapman K, et al. Impact of a nutrition and physical activity intervention (ENRICH: Exercise and Nutrition Routine Improving Cancer Health) on health behaviors of cancer survivors and carers: a pragmatic randomized controlled trial. BMC Cancer 2015;15:710.
Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011;103:1827–1839.
Testino G. The burden of cancer attributable to alcohol consumption. Maedica (Bucur) 2011;6:313–320.
Ratna A, Mandrekar P. Alcohol and cancer: mechanisms and therapies. Biomolecules 2017;7:61.
Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 2013;24:301–308.
Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site- specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015;112:580–593.
Cao Y, Willett WC, Rimm EB, et al. Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ 2015;351:h4238.
Sarich P, Canfell K, Egger S, et al. Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over. Br J Cancer 2021;124:513–523.
Islami F, Tramacere I, Rota M, et al. Alcohol drinking and laryngeal cancer: overall and dose-risk relation--a systematic review and meta-analysis. Oral Oncol 2010;46:802–810.
Di Credico G, Polesel J, Dal Maso L, et al. Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer 2020;123:1456–1463.
GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet 2022;400:185–235.
Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol 2021;22:1071–1080.
Gapstur SM, Bandera EV, Jernigan DH, et al. Alcohol and cancer: existing knowledge and evidence gaps across the cancer continuum. Cancer Epidemiol Biomarkers Prev 2022;31:5–10.
Goding Sauer A, Fedewa SA, Bandi P, et al. Proportion of cancer cases and deaths attributable to alcohol consumption by US state, 2013-2016. Cancer Epidemiol 2021;71(Pt A):101893.
Naimi TS, Brown DW, Brewer RD, et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med 2005;28:369–373.
van de Luitgaarden IAT, van Oort S, Bouman EJ, et al. Alcohol consumption in relation to cardiovascular diseases and mortality: a systematic review of Mendelian randomization studies. Eur J Epidemiol 2022;37:655–669.
Oppenheimer GM, Bayer R. Is moderate drinking protective against heart disease? The science, politics and history of a public health conundrum. Milbank Q 2020;98:39–56.
Biddinger KJ, Emdin CA, Haas ME, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open 2022;5:e223849.
Sanford NN, Sher DJ, Xu X, et al. Alcohol use among patients with cancer and survivors in the United States, 2000-2017. J Natl Compr Canc Netw 2020;18:69–79.
Lyu J, Kaur M, Dibble KE, et al. A national study of alcohol consumption patterns among population-based U.S. cancer survivors compared with cancer-free individuals. Cancer Epidemiol 2022;77:102101.
Delker E, Brown Q, Hasin DS. Alcohol consumption in demographic subpopulations: an epidemiologic overview. Alcohol Res 2016;38:7–15.
Lehavot K, Browne KC, Simpson TL. Examining sexual orientation disparities in alcohol misuse among women veterans. Am J Prev Med 2014;47:554–562.
Hatzenbuehler ML, Corbin WR, Fromme K. Trajectories and determinants of alcohol use among LGB young adults and their heterosexual peers: results from a prospective study. Dev Psychol 2008;44:81–90.
Hatzenbuehler ML, McLaughlin KA, Xuan Z. Social networks and sexual orientation disparities in tobacco and alcohol use. J Stud Alcohol Drugs 2015;76:117–126.
Huang Q, Luo K, Yang H, et al. Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up. Cancer Sci 2014;105:1638–1646.
Thrift AP, Nagle CM, Fahey PP, et al. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer 2012;131:E759–768.
Fahey PP, Mallitt KA, Astell-Burt T, et al. Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis. Cancer Causes Control 2015;26:1365–1373.
Ferronha I, Bastos A, Lunet N. Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta- analysis. Eur J Cancer Prev 2012;21:449–452.
Lemieux J, Diorio C, Côté MA, et al. Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab. Anticancer Res 2013;33:2569–2576.
Zhao L, Cull Weatherer A, Kerch S, et al. Alcohol use during chemotherapy: a pilot study. WMJ 2022;121:157–159.
Huang Z, Shi Y, Bao P, et al. Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors. Breast Cancer Res Treat 2018;171:189–198.
Couvertier-Lebron CE, Dove R, Acevedo SF. What you do not know could hurt you: what women wish their doctors had told them about chemotherapy side effects on memory and response to alcohol. Breast Cancer (Auckl) 2016;10:229–238.
Uomori T, Horimoto Y, Mogushi K, et al. Relationship between alcohol metabolism and chemotherapy-induced emetic events in breast cancer patients. Breast Cancer 2017;24:702–707.
LoConte NK, Brewster AM, Kaur JS, et al. Alcohol and cancer: a statement of the American Society of Clinical Oncology. J Clin Oncol 2018;36:83–93.
Fortin A, Wang CS, Vigneault E. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2009;74:1062–1069.
Yang B, Gapstur SM, Newton CC, et al. Alcohol intake and mortality among survivors of colorectal cancer: the Cancer Prevention Study II Nutrition cohort. Cancer 2017;123:2006–2013.
van Zutphen M, Kampman E, Giovannucci EL, et al. Lifestyle after colorectal cancer diagnosis in relation to survival and recurrence: a review of the literature. Curr Colorectal Cancer Rep 2017;13:370–401.
Farris MS, Courneya KS, Kopciuk KA, et al. Post-diagnosis alcohol intake and prostate cancer survival: a population-based cohort study. Int J Cancer 2018;143:253–262.
Li Y, Mao Y, Zhang Y, et al. Alcohol drinking and upper aerodigestive tract cancer mortality: a systematic review and meta-analysis. Oral Oncol 2014;50:269–275.
Huang CC, Hsiao JR, Lee WT, et al. Investigating the association between alcohol and risk of head and neck cancer in Taiwan. Sci Rep 2017;7:9701.
Simapivapan P, Boltong A, Hodge A. To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: a systematic review. Cancer Treat Rev 2016;50:155–167.
Park SM, Li T, Wu S, et al. Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma. Cancer Epidemiol 2017;47:106–113.
Druesne-Pecollo N, Keita Y, Touvier M, et al. Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2014;23:324–331.
Choi YJ, Myung SK, Lee JH. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res Treat 2018;50:474–487.
Scoccianti C, Cecchini M, Anderson AS, et al. European Code against Cancer 4th edition: alcohol drinking and cancer. Cancer Epidemiol 2015;(39 Suppl):S67–74.
Bagnardi V, Blangiardo M, La Vecchia C, et al. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85:1700–1705.
Chen WY, Rosner B, Hankinson SE, et al. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 2011;306:1884–1890.
Marziliano A, Teckie S, Diefenbach MA. Alcohol-related head and neck cancer: summary of the literature. Head Neck 2020;42:732–738.
World Cancer Research Fund, American Institute for Cancer Research. Alcoholic drinks and the risk of cancer. Accessed July 27, 2022. Available at: https://www.wcrf.org/wp-content/uploads/2021/02/Alcoholic-Drinks.pdf
Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin 2020;70:245–271.
Rock CL, Thomson CA, Sullivan KR, et al. American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 2022;72:230–262.
U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2020-2025. 9th ed. Accessed July 27, 2022. Available at: https://www.dietaryguidelines.gov/sites/default/files/2021-03/Dietary_Guidelines_for_Americans-2020-2025.pdf
Wozniak MB, Brennan P, Brenner DR, et al. Alcohol consumption and the risk of renal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2015;137:1953–1966.
Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007;99:1801–1810.
Auguste A, Deloumeaux J, Joachim C, et al. Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies. Cancer Med 2020;9:6854–6863.
Gormley M, Dudding T, Sanderson E, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun 2020;11:6071.
Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99:777–789.
Flatt SW, Thomson CA, Gold EB, et al. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 2010;19:681–688.
Newcomb PA, Kampman E, Trentham-Dietz A, et al. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol 2013;31:1939–1946.
Gou YJ, Xie DX, Yang KH, et al. Alcohol consumption and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev 2013;14:4785–4790.
Terry K, Mayer DK, Wehner K. Alcohol consumption: discussing potential risks for informed decisions in breast cancer survivors. Clin J Oncol Nurs 2021;25:672–679.
Vrieling A, Buck K, Heinz J, et al. Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res Treat 2012;136:195–207.
Kwan ML, Kushi LH, Weltzien E, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 2010;28:4410–4416.
Weaver AM, McCann SE, Nie J, et al. Alcohol intake over the life course and breast cancer survival in Western New York Exposures and Breast Cancer (WEB) study: quantity and intensity of intake. Breast Cancer Res Treat 2013;139:245–253.
McNabb S, Harrison TA, Albanes D, et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer 2020;146:861–873.
Phipps AI, Robinson JR, Campbell PT, et al. Prediagnostic alcohol consumption and colorectal cancer survival: the Colon Cancer Family Registry. Cancer 2017;123:1035–1043.
Kim Y, Je Y, Giovannucci EL. Association between alcohol consumption and survival in colorectal cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2019;28:1891–1901.
Walter V, Jansen L, Ulrich A, et al. Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr 2016;103:1497–1506.
Vieira AR, Abar L, Chan DSM, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol 2017;28:1788–1802.
Papadimitriou N, Bouras E, van den Brandt PA, et al. A prospective diet-wide association study for risk of colorectal cancer in EPIC. Clin Gastroenterol Hepatol 2022;20:864–873.e13.
Kwon HJ, Lee JW, Chung NG, et al. Assessment of serologic immunity to diphtheria-tetanus-pertussis after treatment of Korean pediatric hematology and oncology patients. J Korean Med Sci 2012;27:78–83.
Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009;44:521–526.
Colton H, Greenfield DM, Snowden JA, et al. Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant. Vaccine 2021;39:4778–4783.
Walti CS, Krantz EM, Maalouf J, et al. Antibodies against vaccine- preventable infections after CAR-T cell therapy for B cell malignancies. JCI Insight 2021;6:e146743.
Underwood JM, Townsend JS, Stewart SL, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 2012;61:1–23.
Snyder CF, Frick KD, Peairs KS, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med 2009;24:469–474.
Locher JL, Rucks AC, Spencer SA, et al. Influenza immunization in older adults with and without cancer. J Am Geriatr Soc 2012;60:2099–2103.
Mandelzweig L, Chetrit A, Amitai T, et al. Primary prevention and screening practices among long-term breast cancer survivors. Cancer Causes Control 2017;28:657–666.
Pophali PA, Larson MC, Allmer C, et al. Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors. J Cancer Surviv 2020;14:316–321.
Chang A, Ellingson MK, Flowers CR, et al. Influenza vaccination rates among patients with a history of cancer: analysis of the national health interview survey. Open Forum Infect Dis 2021;8:ofab198.
Kawano Y, Suzuki M, Kawada J, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine 2015;33:1440–1445.
Shah GL, Shune L, Purtill D, et al. Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies. Biol Blood Marrow Transplant 2015;21:2160–2166.
Small TN, Zelenetz AD, Noy A, et al. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2009;15:1538–1542.
NCCN: Cancer and COVID-19 Vaccination. Recommendations of the National Comprehensive Cancer Network® (NCCN®) Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis. Accessed July 28, 2022. Available at: https://www.nccn.org/covid-19
Platt HL, Cardona JF, Haranaka M, et al. A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine 2022;40:162–172.
Klein NP, Peyrani P, Yacisin K, et al. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine 2021;39:5428–5435.
Wasserman MD, Perdrizet J, Grant L, et al. Clinical and economic burden of pneumococcal disease due to serotypes contained in current and investigational pneumococcal conjugate vaccines in children under five years of age. Infect Dis Ther 2021;10:2701–2720.
Huang L, Wasserman M, Grant L, et al. Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States. Vaccine 2022;40:4700–4708.
Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:109–117.
Bastidas A, de la Serna J, El Idrissi M, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA 2019;322:123–133.
Dagnew AF, Ilhan O, Lee WS, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis 2019;19:988–1000.
Vink P, Delgado Mingorance I, Maximiano Alonso C, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: a randomized trial. Cancer 2019;125:1301–1312.
Anderson TC, Masters NB, Guo A, et al. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:80–84.
Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19-59 years: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:477–483.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 3751 | 3751 | 405 |
PDF Downloads | 1924 | 1924 | 169 |
EPUB Downloads | 0 | 0 | 0 |